Published in Clin Dev Immunol on July 25, 2011
Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59
Dietary grape seed extract ameliorates symptoms of inflammatory bowel disease in IL10-deficient mice. Mol Nutr Food Res (2013) 0.84
Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis. Lipids Health Dis (2013) 0.80
Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. Dig Dis Sci (2015) 0.75
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29
Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol (1993) 9.97
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity (1994) 9.63
Myeloperoxidase: friend and foe. J Leukoc Biol (2005) 7.16
Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10
Th17 and regulatory T cells in mediating and restraining inflammation. Cell (2010) 5.89
Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity (2009) 5.43
Regulatory T cells and intestinal homeostasis. Immunol Rev (2005) 3.82
Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun (1997) 3.21
E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity (2010) 2.78
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut (2003) 2.37
Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood (2009) 2.23
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog (2008) 2.21
Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A (2010) 2.19
Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol (2008) 2.05
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Mesenteric lymph nodes at the center of immune anatomy. J Exp Med (2006) 1.70
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.70
Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci U S A (2009) 1.61
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One (2009) 1.60
Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun (2003) 1.48
Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr (2008) 1.48
A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One (2010) 1.45
Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther (2006) 1.42
Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther Immunol (1995) 1.33
A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota. J Exp Med (2010) 1.32
IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol Lett (2009) 1.31
Probiotic effects on inflammatory bowel disease. J Nutr (2007) 1.29
Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells. Immunol Lett (2005) 1.20
Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis (2009) 1.16
Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis (2011) 1.16
Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition (2003) 1.13
Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol (2001) 1.11
Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics (2005) 1.11
Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells. Gastroenterology (2002) 1.09
Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol (2008) 1.04
Probiotics and chronic disease. J Clin Gastroenterol (2006) 0.99
Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother (2003) 0.96
Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease. Novartis Found Symp (2004) 0.96
Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis. J Leukoc Biol (2005) 0.94
Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Mol Nutr Food Res (2008) 0.89
Probiotic preparation VSL#3 alters the distribution and phenotypes of dendritic cells within the intestinal mucosa in C57BL/10J mice. J Nutr (2009) 0.87
Immunopathogenesis of IBD: insufficient suppressor function in the gut? Gut (2006) 0.84
Multistep mechanism of probiotic bacterium, the effect on innate immune system. Mol Nutr Food Res (2010) 0.81
Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis. Dis Colon Rectum (2008) 0.80
Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood (2007) 2.78
Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood (2009) 2.23
Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics (2007) 2.07
Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells. J Immunol (2009) 1.45
Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis (2007) 1.37
Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun (2005) 1.13
Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One (2009) 1.06
New insights into the proliferation and differentiation of early mouse thymocytes. Int Immunol (2004) 1.05
Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc Nutr Soc (2010) 1.05
Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol (2009) 1.02
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector. Mol Ther (2006) 1.01
Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. J Proteome Res (2011) 1.01
Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells. Immunology (2005) 0.99
The B lineage potential of thymus settling progenitors is critically dependent on mouse age. Eur J Immunol (2007) 0.97
Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA. J Biol Chem (2010) 0.93
The role of secretory immunoglobulin A in the natural sensing of commensal bacteria by mouse Peyer's patch dendritic cells. J Biol Chem (2012) 0.92
Peripheral T lymphocytes recirculating back into the thymus can mediate thymocyte positive selection. J Immunol (2008) 0.91
Time-resolved quantitative proteome analysis of in vivo intestinal development. Mol Cell Proteomics (2010) 0.90
Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium. Infect Immun (2004) 0.89
Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol (2011) 0.88
Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol (2006) 0.87
Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development. PLoS One (2008) 0.86
Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Exp Dermatol (2009) 0.85
Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress. J Nutr Biochem (2012) 0.84
Influence of gut microbiota on mouse B2 B cell ontogeny and function. Mol Immunol (2011) 0.83
Intake of a milk-based wolfberry formulation enhances the immune response of young-adult and aged mice. Rejuvenation Res (2010) 0.82
Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. Eur J Dermatol (2008) 0.82
Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. J Pediatr Gastroenterol Nutr (2011) 0.82
Immunomodulatory effects of dietary supplementation with a milk-based wolfberry formulation in healthy elderly: a randomized, double-blind, placebo-controlled trial. Rejuvenation Res (2012) 0.81
In interleukin-7-transgenic mice, increasing B lymphopoiesis increases follicular but not marginal zone B cell numbers. Eur J Immunol (2003) 0.81
Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice. Rejuvenation Res (2008) 0.81
Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis. Lipids Health Dis (2013) 0.80
Role of secretory IgA in the mucosal sensing of commensal bacteria. Gut Microbes (2014) 0.80
The preTCR-dependent DN3 to DP transition requires Notch signaling, is improved by CXCL12 signaling and is inhibited by IL-7 signaling. Eur J Immunol (2011) 0.80
Prophylactic effect of oral administration of Lactobacillus johnsonii NCC533 (La1) during the weaning period on atopic dermatitis in NC/NgaTnd mice. Eur J Dermatol (2008) 0.80
Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats. Clin Sci (Lond) (2003) 0.79
Problems defining DN2 thymocytes. Immunol Cell Biol (2008) 0.79
Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol (2010) 0.78
A stromal cell free culture system generates mouse pro-T cells that can reconstitute T-cell compartments in vivo. Eur J Immunol (2014) 0.78
Effect of supplementation with Enterococcus faecium (SF68) on immune functions in cats. Vet Ther (2007) 0.77
Anti-inflammatory effects of Lacto-Wolfberry in a mouse model of experimental colitis. World J Gastroenterol (2012) 0.75
Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation. Eur J Dermatol (2011) 0.75
Lactobacillus johnsonii provides a dose-dependent protection against UVR-induced immunosuppression. Eur J Dermatol (2008) 0.75